Phase 4 N=5 Treatment

Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community

Tobacco Dependence

Bottom Line

View on ClinicalTrials.gov: NCT06289192 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Sep 2025

Primary outcome: Primary: Acceptability and Feasibility as Assessed by the Number of Participants Who Complete Intervention and Surveys — 5; 5 Participants

Study Design & Population

Study type: Interventional
Phase: Phase 4
Interventions: C-Raven Virtual Tobacco Cessation Counseling (Behavioral); Nicotine Replacement Product (Drug); Community Health Worker (Other); Lung Cancer Screening (Other)
Age: Adult, Older Adult · 50+ yrs
Sex: All
Sponsor: Johns Hopkins University
Primary completion: Aug 2024

Outcome Measures

Outcome	Result	p-value
PRIMARY Acceptability and Feasibility as Assessed by the Number of Participants Who Complete Intervention and Surveys	5; 5	—
PRIMARY Acceptability and Feasibility as Assessed by Barriers to Screening	25.2; 28.6; 31.8	—
SECONDARY Number of Participants That Uptake Nicotine Replacement Therapy	4	—
SECONDARY Participant Engagement With Community Health Worker (CHW) as Assessed by Number of CHW Interactions	60	—

Summary

To inform a future randomized trial of a virtual counselor led computer delivered intervention for tobacco cessation augmented with community health worker (CHW) support and navigation to lung cancer screening in low-income housing units in Baltimore, the investigators propose to collect data on intervention acceptability and feasibility among individuals in public housing as well as feedback on use of shared decision making when referring for low-dose chest CT (LDCT). The investigators will conduct a feasibility pilot study of a virtual counselor plus community health worker intervention. With a sample of participants from public housing units (N=15), the investigators will collect data on feasibility of recruitment, intervention engagement and completion, and short-term smoking cessation outcomes. Individuals will be assessed at baseline, 1 month and 3 months. At the end of three months, the investigators will conduct follow up interviews with a subset of pilot participants to collect qualitative data on intervention acceptability. Based on this information, the investigators will make iterative improvements to the combined intervention.

Eligibility Criteria

Inclusion Criteria

Age 50 or older
Current tobacco use with >100 cigarettes smoked in their lifetime
English speaking (intervention currently in English only and housing units are in largely English-speaking neighborhoods)
Considering smoking cessation
Planning to remain in current housing unit for 6 months

Exclusion Criteria

Current use of pharmacological treatment for tobacco cessation
Contraindication to nicotine replacement therapy
Current engagement in formal smoking cessation program
Major cognitive or psychiatric impairment
Severe hearing impairment
Investigator discretion

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06289192). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.